BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05673928-completion@plaintrial.com
DTSTAMP:20261027T050358Z
DTSTART;VALUE=DATE:20290301
SUMMARY:A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1)
  in Patients With HER2-positive Metastatic Solid Tumors and Metastases to 
 Brain (TUCATEMEB) — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05673928
URL:https://plaintrial.com/trial/NCT05673928
END:VEVENT
END:VCALENDAR